Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2012 /
A new direction for development of targeted cancer therapies

28th - 29th Jun 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.07.12
Views: 2794
Rating:

Dr Edison Liu – Jackson Laboratory, USA

Dr Edison Liu discusses how genome sequencing can be used in order to identify novel targets for cancer therapy.

 

Dr Liu explains how the similarities between multiple cancers can be more useful to drug development that than identifying features unique to a specific disease.

 

It is hoped that by evaluating the networks of pathways that control a cancer, it will be possible to target cancers more effectively and reduce the likelihood of treatment resistance. 

 

Filming supported by Amgen

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation